Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

0.860
-0.015-1.71%
Volume:497.50K
Turnover:429.65K
Market Cap:620.92M
PE:-2.38
High:0.925
Open:0.925
Low:0.850
Close:0.875
52wk High:2.340
52wk Low:0.850
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:0.85
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.361
ROE:-7.67%
ROA:-7.02%
PB:0.24
PE(LYR):-2.38
PS:15.24

Loading ...

BRII-B Executes HK$0.09 Million Share Buyback, Reducing Outstanding Shares by 0.01%

Bulletin Express
·
10 mins ago

BRII-B (02137) Allocates HK$86,000 for Share Buyback on September 16

Stock News
·
26 mins ago

Brii Biosciences Completes Additional Share Buyback; Treasury Stock Rises to 12.92 Million Shares

Bulletin Express
·
Aug 31

Brii Biosciences Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Aug 31

HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%

Tiger Newspress
·
Aug 26

Brii Bio Repurchases 120,000 Shares; Treasury Stock Rises to 12.90 Million

Bulletin Express
·
Aug 25

Brii-Biosciences (BRII-B) Issues 0.26 Million New Shares Under Employee Schemes; Repurchases 0.06 Million Shares Into Treasury

Bulletin Express
·
Aug 24

BRII-B (02137) Buys Back 60,000 Shares for HK$60,300 on August 24

Stock News
·
Aug 24

Brii Biosciences Files HKEX Next-Day Disclosure, Lifts Share Capital by 255,793 Shares

Reuters
·
Aug 24

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Reuters
·
Aug 24

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges

Stock News
·
Aug 21

China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 21

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

THOMSON REUTERS
·
Aug 21

Brii Biosciences: Hy Other Income Rmb19.5 Mln

THOMSON REUTERS
·
Aug 21

Brii Bio H1 FY26 Loss Narrows 32.1% to RMB 101 Million

Reuters
·
Aug 21

Brii Biosciences Sets 20 August 2026 Board Meeting to Review 1H26 Interim Results

Bulletin Express
·
Aug 07

Brii Biosciences Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 07

Analyzing the First Half Fiscal Revenue and Expenditure Growth Rates in 2026

Deep News
·
Jul 29